TC
MON

Trilogy Capital’s Monsanto Co MON Stock Holding History

Trilogy Capital’s Portfolio MON Stock Details MON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,696
Closed -$315K – 649
2018
Q1 		$315K Hold
2,696
– – 0.05% 96
2017
Q4 		$315K Buy
+2,696
New +$321K 0.05% 94

Other funds holding MON

LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
UFF
USA Financial Formulas Ada, Michigan $531M AUM 28.6% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Trilogy Capital's MON Position: Q2 2018 in Review

Trilogy Capital sold out of Monsanto Co (MON) in Q2 2018, closing a stake of 2,696 shares — an estimated $315K sold.

Trilogy Capital first reported a position in MON in Q4 2017 and held it in 2 quarters. The position peaked at $315K in Q1 2018. 4 funds tracked by Wall St. Rank hold MON as of Q2 2018.

  • Trilogy Capital reported no remaining Monsanto Co position as of Q2 2018 after selling out during the quarter.
  • Trilogy Capital sold 2,696 Monsanto Co shares in Q2 2018, an estimated $315K.
  • Trilogy Capital first reported a position in Monsanto Co in Q4 2017 and held it in 2 quarters.
  • Trilogy Capital's Monsanto Co position peaked at $315K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Monsanto Co as of Q2 2018.

Based on Trilogy Capital's 13F filing for Q2 2018, filed 20 Aug 2018.